{"paper_id":"1f9734a6-adac-4e5e-b535-5f716379e3d2","body_text":"Published November 8, 2025\n| Version v1\nOther\nOpen\nIn women with moderate to severe endometriosis, does treatment with anti-inflammatory cytokine modulators (such as TNF-α inhibitors) compared with standard hormonal therapy or placebo result in greater regression of endometriotic lesions and symptom improvement?\nDescription\nCurrently, there is limited clinical evidence regarding the effectiveness of TNF-α inhibitors compared to standard hormonal therapy or placebo in reducing endometriotic lesions and symptoms. More research is needed to establish their role in endometriosis treatment.\nFiles\n94ae4f93-5c00-4c6c-b3ea-0bda40b2c241.pdf\nFiles\n(18.7 kB)\n| Name | Size | Download all |\n|---|---|---|\n|\nmd5:23d9e16c8b79db6c854f2a4cf032fe4c\n|\n18.7 kB | Preview Download |","source_license":"CC0","license_restricted":false}